nilotinib - Robuta Search

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13b46e09-62d2-4ce9-b3c0-deafcb1f1842 DailyMed - NILOTINIB capsule dailymed nilotinib capsule https://eprints.ncl.ac.uk/297515 Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial -... https://www.flmd.uscourts.gov/cases-of-interest/tasigna-nilotinib-products-liability-litigation-mdl-no-3006 Tasigna (Nilotinib) Products Liability Litigation, MDL No. 3006 | Middle District of Florida |... products liability litigation https://adisinsight.springer.com/trials/700303406?error=cookies_not_supported&code=48b89333-e97f-4875-b8e9-bed16572827a Effect of food consumption on pharmacokinetics of nilotinib in Chronic Myeloid Leukemia -... The purpose of this study is to evaluate the effects of food on pharmacokinetics of nilotinib in chronic myeloid leukemia patients. food consumption effect https://recalls-rappels.canada.ca/en/alert-recall/tasigna-nilotinib-possible-risk-developing-atherosclerosis-related-conditions-public TASIGNA (nilotinib) - Possible Risk of Developing Atherosclerosis-Related Conditions - For the... related conditions tasigna nilotinib possible risk https://www.cancer.gov/news-events/cancer-currents-blog/2018/nilotinib-cml-fda-discontinue Discontinuing Nilotinib in Patients with CML - NCI FDA now says nilotinib (Tasignia) can be safely stopped in some patients with CML whose cancer has been in remission for an extended period. in patients discontinuing nilotinib cml nci https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-nilotinib-for-children-and-young-people-with-philadelphia-positive-leukaemia A trial of nilotinib for children and young people with Philadelphia positive leukaemia This trial looked at nilotinib for children and young people whose leukaemia had the Philadelphia chromosome. for children and young people https://pubchem.ncbi.nlm.nih.gov/compound/Nilotinib Nilotinib | C28H22F3N7O | CID 644241 - PubChem Nilotinib | C28H22F3N7O | CID 644241 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities,... nilotinib cid pubchem https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/69097-0030/ 69097-0030 Nilotinib - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. nilotinib ndc https://pubmed.ncbi.nlm.nih.gov/19108785/?dopt=Abstract Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous... Nilotinib is an oral second-generation bcr-abl TKI indicated for the treatment of imatinib resistant or -intolerant Ph+ CML-CP and -AP in adults. Positive... https://adisinsight.springer.com/drugsafety/803444202?error=cookies_not_supported&code=1ed06f4a-9738-43e0-9ac2-2df445ddcffd Dasatinib/nilotinib - AdisInsight In a case series, 2 patients (a 45-year-old woman and a 36-year-old man) were described, who developed nilotinib resistance during treatment for chronic myeloid dasatinib nilotinib adisinsight https://www.medlineplus.gov/druginfo/meds/a608002.html Nilotinib: MedlinePlus Drug Information Nilotinib: learn about side effects, dosage, special precautions, and more on MedlinePlus nilotinib medlineplus drug information https://adisinsight.springer.com/trials/700047461?error=cookies_not_supported&code=82ed5c5b-0260-4cd9-9c6e-4ab66971b50d A phase II trial of nilotinib in the treatment of c-KIT mutated advanced acral and mucosal melanoma... This study investigated the efficacy and tolerability of nilotinib [Tasigna; Novartis] in patients with c-KIT mutated advanced malignant melanoma (acral and https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-nilotinib-for-newly-diagnosed-chronic-myeloid-leukaemia-enest1st A trial looking at nilotinib for newly diagnosed chronic myeloid leukaemia (ENEST1st) This trial looked at nilotinib for people with newly diagnosed chronic myeloid leukaemia (CML) with the Philadelphia chromosome. for newly diagnosed chronic myeloid leukaemia looking at https://en.wikipedia.org/wiki/List_of_adverse_effects_of_nilotinib List of adverse effects of nilotinib - Wikipedia list of adverse effects nilotinib wikipedia https://adisinsight.springer.com/drugsafety/803006667?error=cookies_not_supported&code=f4765670-e79d-4f32-9a31-2be389358d6e Fluorouracil/nilotinib - AdisInsight A 72-year-old man, who was receiving nilotinib 400 mg/day [duration of therapy not stated] for chronic myeloid leukaemia, developed an intense inflammatory fluorouracil nilotinib adisinsight https://www.mayoclinic.org/es/drugs-supplements/nilotinib-oral-route/description/drg-20071399 Nilotinib (oral route) - Side effects & dosage - Mayo Clinic side effects nilotinib oral route dosage https://adisinsight.springer.com/drugsafety/803924513?error=cookies_not_supported&code=ab5687e4-5905-485e-8e39-e578030dd51d Nilotinib - AdisInsight Two patients with chronic myeloid leukaemia developed severe carotid atherosclerotic stenoses resulting in ischaemic stroke during long-term treatment with nilotinib adisinsight